The pharmaceutical industry is paying attention to whether Janssen’s Imbruvica (ingredient: ibrutinib) plus Abbvie's Venclexta (venetoclax) will become a new treatment option in blood cancer.At the American Society of Clinical Oncology (ASCO 2021) online meeting from Friday to Tuesday next week, com
The pace of the Covid-19 vaccination program is accelerating in Korea.Since late May, the health authorities allowed non-priority people to receive leftover Covid-19 vaccines, made available from canceled appointments or uses of low dead space syringes.Just in three months after the vaccination star
Pfizer Korea denied a media report on Tuesday concerning the Daegu Metropolitan Government’s push to introduce Pfizer's Covid-19 vaccine separately from the central government."Amid the Covid-19 pandemic, Pfizer is supplying its Covid-19 vaccines to only central governments and state regulators," a
Amgen has recently obtained the first-ever FDA approval for sotorasib (brand name: Lumakras), a treatment for KRAS G12-mutated non-small cell lung cancer (NSCLC).NSCLC with KRAS mutation has remained untreated for over 40 years.On Friday, the FDA approved the use of sotorasib, an oral KRAS G12C inhi
ST Pharm said it would develop the nation’s first lipid nanoparticle (LNP)-based Covid-19 mRNA vaccine that can respond to variant cases.In developing the vaccine, the company plans to apply Genevant Science's LNP technology, used in developing Pfizer and Moderna's mRNA vaccine, and its patented 5’-
Large Korean biopharmaceutical companies have released their financial reports for the first quarter, demonstrating mixed performances.Some companies began to recover from the Covid-19’s fallout that has lasted for more than a year, while others remained in the doldrum for various reasons.Samsung Bi
Korean pharmaceutical companies are rushing to enter the pet treatment market, focusing R&D particularly on diseases like diabetes and cognitive impairment from which old pets tend to suffer.In 2019, 5.9 million Korean households, or 26.4 percent of the total, raised a pet. Industry officials said t
Local pharmaceutical companies are expediting the development of antidepressants as more people suffer from anxiety and depression amid the coronavirus pandemic.According to a survey by Korea Health Promotion Institute, 40.7 percent of the respondents said they experienced anxiety and depression bec
AstraZeneca said Monday that the Ministry of Food and Drug Safety has approved Koselugo (ingredient: selumetinib) for treating pediatric patients with neurofibromatosis type 1 (NF1) above three years old.The Korean regulator approved the drug to treat NF1 patients accompanying plexiform neurofibroma
GSK and Vir Biotechnology said Friday that their Covid-19 drug candidate VIR-7831 has received emergency use authorization (EUA) from the U.S. Food and Drug Administration. FDA granted the EUA for the single monoclonal antibody candidate developed by GSK and Vir to treat and prevent mild and moderat
Novartis Korea said Friday that the Ministry of Food and Drug Safety has approved Zolgensma, gene therapy for spinal muscular atrophy (SMA).Hospitals can use the drug to treat SMA Type 1 patients with a double allelic mutation in the SMN1 gene or three or fewer copies of the SMN Type 2 gene.The mini
Novo Nordisk and Sanofi Aventis, the two dominant insulin providers in Korea, have shown mixed sales performances in the first quarter.According to IQVIA, a drug market research company, Novo Nordisk finally surpassed Sanofi in the first three months, as Tresiba and Ryzodeg generated robust sales in
The European Medicines Agency’s (EMA) Committee for Human Medical Products (CHMP) issued a positive scientific opinion on sotrovimab, a Covid-19 treatment candidate developed by GSK and Vir Biotechnology, GSK said.The CHMP’s evaluation involved the use of sotrovimab for adults and adolescents (aged
Humedix said Thursday that its single-shot formulation Humia for osteoarthritis has obtained Conformite Europeenne certification, and the company would speed up marketing the new medicine in global markets.According to the company, osteoarthritis patients have only need to take one Humia shot per si
Hanmi Pharmaceutical’s Amozaltan XQ, the world's first four-ingredient combination drug for hypertension and dyslipidemia, received positive reviews from medical specialists at an online conference hosted by the Korean Society of Hypertension.“More than half of hypertension patients have dyslipidemi
To develop a globally competitive homegrown blockbuster drug, Korean pharmaceutical companies should choose the most prominent pipelines and concentrate on them, experts said.The Korea Pharmaceutical and Bio-Pharma Manufacturers Association (KPBMA) held a press webinar on the pharmaceutical and biot
The U.S. FDA recently approved Janssen’s Rybrevant (ingredient: amivantamab) as the first targeted therapy for non-small cell lung cancer (NSCLC) patients with epidermal growth factor receptor (EGFR) exon 20 insertion mutations.In Korea, researchers are testing a combination therapy mixing Rybrevant
Daewoong Pharmaceutical said Wednesday that the Indonesian government has promised to provide full support for the Korean drugmaker’s various projects in the Southeast Asian country.Indonesian Minister of Maritime and Investment Affairs Luhut Binsar Pandjaitan and Minister of Health Budi Gunadi Sadi
inno.N will accelerate the research of new anticancer drugs using big data at the National Cancer Center Cancer and Jeonbuk National University Hospital.The company said Wednesday that it plans to use the CONNECT platform, a cancer big data library, to classify target patients, develop biomarkers, s
Biogen is taking a bold step to win U.S. FDA approval for Alzheimer’s treatment candidate aducanumab in June.On Thursday, Biogen announced that its manufacturing facility in Solothurn, Switzerland received a Good Manufacturing Practice (GMP) certification from the Swiss Agency for Therapeutic Produc